Vagus nerve stimulation in treatment-resistant depression: Acute and follow-up results of an italian case series

Journal of ECT

Volumn 29, Issue 1, 2013, Pages 41-44

  Dell'Osso, Bernardo ^a   Oldani, Lucio ^a   Carlotta Palazzo, M ^a   Balossi, Ilaria ^a   Ciabatti, Mariateresa ^a   Carlo Altamura, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

short and long term efficacy; tolerability; treatment resistant depression; vagus nerve stimulation

Indexed keywords

ADULT; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; COMPARATIVE STUDY; DSM-IV-TR; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; TREATMENT RESISTANT DEPRESSION; VAGUS NERVE STIMULATION;

ADULT; AGE OF ONSET; AGED; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ELECTRODES, IMPLANTED; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SUICIDE, ATTEMPTED; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 84874659292     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3182735ef0     Document Type: Article

References (16)

1. Nemeroff CB. Prevalence and management of treatment-resistant depression. J Clin Psychiatry. 2007;68(suppl 8):17-25.
2. Kennedy SH, Giacobbe P, Rizvi SJ, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry. 2011;168:502-510.
3. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):10-17.
4. Pacchiarotti I, Mazzarini L, Colom F, et al. Treatment-resistant bipolar depression: towards a new definition. Acta Psychiatr Scand. 2009;120:429-440.
5. Marangell LB, Martinez M, Jurdi RA, et al. Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatr Scand. 2007;116:174-181.
6. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25:713-728.
7. Daban C, Martinez-Aran A, Cruz N, et al. Safety and efficacy of vagus nerve stimulation in treatment-resistant depression. A systematic review. J Affect Disord. 2008;110:1-15.
8. Nierenberg AA, Alpert JE, Gardner-Schuster EE, et al. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol Psychiatry. 2008;64: 455-460.
9. Nierenberg AA, DeCecco LM. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry. 2001;62(suppl 16):5-9.
10. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, DC: American Psychiatric Press; 1996.
11. Labiner DM, Ahern GL. Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings. Acta Neurol Scand. 2007;115:23-33.
12. Martin JL, Martn-Sanchez E. Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: variable results based on study designs. Eur Psychiatry. 2012;27:147-155.
13. Mohr P, Rodriguez M, Slavckova A, et al. The application of vagus nerve stimulation and deep brain stimulation in depression. Neuropsychobiology. 2011;64:170-181.
14. Sperling W, Reulbach U, Kornhuber J. Clinical benefits and cost effectiveness of vagus nerve stimulation in a long-term treatment of patients with major depression. Pharmacopsychiatry. 2009; 42:85-88.
15. Miklowitz DJ. Functional impairment, stress, and psychosocial intervention in bipolar disorder. Curr Psychiatry Rep. 2011;13:504-512.
16. Vieta E, Carne X. The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate. Psychother Psychosom. 2005;74:10-16.